Articles tagged with: HEB

Hemispherx Biopharma, Inc. (AMEX:HEB) is in the news after it was announced that Dr. Hasegawa the director of the Japanese National Institute of Infectious Diseases presented data on the lead compounds of Ampligen (R) (Poly …

Justin Hall a blogger from SeekingAlpha says the FDA Calendar “should be free”in a recent blog entry.
After reading this I decided to check out Justin profile, since I have never heard of him, and I …

I find it odd thatAradigm Corporation(OTC:ARDM) stock price dropped the day after Zogenix, Inc. was granted approval of the Sumavel™ DosePro. ARDM gets a $4 Million milestone payment upon first commercial sale and royalty payments …

Aradigm Corporation (ARDM) is pending a FDA decision on their drug Liposomal Ciprofloxacin. Lets see if the FDA meets their target date. The FDA has recently misses some important target dates with Hemispherx BioPharma, Inc (Public, AMEX:HEB), Discovery …

Reading some of the posts on the Yahoo message boards I see a lot of people talking about Hemispherix Biopharma (AMEX:HEB)trading is now halted. Obviously this is not true since the stock is not on the …

It has been over a month since the FDA last informed Hemispherx Biopharma (AMEX:HEB) “it may require up to 1-2 additional weeks” to make its decision on HEB’s drug Ampligen, a treatment for Chronic Fatigue …